Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 9, 2014, Pages

  Teo, Edward ^a   House, Hugh ^a   Lockhart, Kathleen ^a   Purchuri, Sai Navya ^a   Pushparajah, Jennifer ^a   Cripps, Allan W ^b   van Driel, Mieke L ^c,d,e  

^a BOND UNIVERSITY   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d BOND UNIVERSITY   (Australia)

^e GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE VACCINE; PLACEBO; ANTIINFECTIVE AGENT; HAEMOPHILUS VACCINE;

ADULT; AGED; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VACCINATION; BRONCHITIS, CHRONIC; DISEASE COURSE; IMMUNOLOGY; META ANALYSIS; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SECONDARY PREVENTION; VERY ELDERLY;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BRONCHITIS, CHRONIC; DISEASE PROGRESSION; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS VACCINES; HUMANS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SECONDARY PREVENTION;

EID: 84907828429     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010010.pub2     Document Type: Review

References (32)

1. Clancy R, Cripps A, Murree-Allen K, Yeung S, Engel M. Oral immunisation with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease. Lancet 1985;2(8469-70):1395-7.
2. Clancy R, Cripps A, Pang G, Yeung S, Murree-Allen K. The paradox of immunisation against Haemophilus influenzae-related endobronchitis: protection restricted to ingestion of 'non-adjuvenated' vaccine. Advances in Experimental Medicine and Biology 1987;216b:1759-64.
3. Clancy RL, Cripps AW. Protection against recurrent acute bronchitis after oral immunisation with killed Haemophilus influenzae. Medical Journal of Australia 1990;152(8):413-6.
4. Clancy R, Dunkley M. Age dependant protection following oral immunisation with inactivated non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease. Newcastle University and Bioxyne Pty Ltd.
5. Lehmann D, Coakley KJ, Coakley CA, Spooner V, Montgomery J, Michael A, et al.Reduction in the incidence of acute bronchitis by an oral Haemophilus influenzae vaccine in patients with chronic bronchitis in the highlands of Papua New Guinea. American Review of Respiratory Disease 1991;144(2):324-30.
6. Tandon MK. Double-blind control trial of oral immunisation trial with killed Haemophilus influenzae (Bronchostat) in elderly chronic obstructive airway disease patients. Australian & New Zealand Journal of Medicine Supplement 1990;19(5):650.
7. Tandon MK, Gebski V. A controlled trial of a killed Haemophilus influenzae vaccine for prevention of acute exacerbations of chronic bronchitis. Australian & New Zealand Journal of Medicine 1991;21(4):427-32.
8. Philips M, Tandon M, Warterer G, Dunkley M, Clancy R. HI-164 an oral vaccine to non-typeable haemophilus influenzae reduces antibiotic use respiratory exacerbations and hospitalisations in patients with COPD. European Respiratory Journal 2007;30:224.
9. Tandon M, Phillips M, Waterer G, Dunkley M, Comans P, Clancy R. Oral immunotherapy with inactivated nontypeable Haemophilus influenzae reduces severity of acute exacerbations in severe COPD. Chest 2010;137(4):805-11.
10. Clancy RL, Dunkley ML. Oral non-typeable Haemophilus influenzae enhances physiological mechanism of airways protection. Clinical & Experimental Immunology 2010;161(1):127-33.
11. ACTRN12606000074594 . A multi-centre, double blind, placebo controlled, prospective study to assess safety and efficacy of orally administered killed whole cell nontypeable Haemophilus influenzae (NTHi) HI-1-164 in preventing episodes of acute bronchitis in patients with moderate to severe airway disease. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12606000074594. Australia, 2013.
12. ACTRN12606000076572 . A multi-centre, double blind, placebo controlled, prospective study to assess safety and efficacy of orally administered killed whole cell nontypeable Haemophilus influenzae (NTHi) HI-1-164 in preventing episodes of acute bronchitis in patients with mild to moderate airway disease. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=1121. Australia, 2013.
13. ACTRN12610000916044 . A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Single-Season Study to Assess the Efficacy and Safety of HI-164OV, an Enteric-coated Oral Vaccine Tablet Containing 45 mg HI-164 Active Substance (Inactivated, Whole Cells of Non-typeable Haemophilus influenzae, isolate 164) for Reducing the Rate and Severity of Acute Exacerbations in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12610000916044. Australia, 2013.
14. Albert RK, Connett J, Bailey WC, Casaburi R, Cooper JA Jr, Criner GJ, et al. Azithromycin for prevention of exacerbations of chronic obstructive pulmonary disease. New England Journal of Medicine 2011;365:689-98.
15. Butt HL, Clancy RL, Cripps AW, Murree-Allen K, Saunders NA, Sutherland D, et al.Bacterial colonisation of the respiratory tract in chronic bronchitis. Australian and New Zealand Journal of Medicine 1990;20(1):35-8.
16. Clancy R, Dunkley M. Acute exacerbations in COPD and their control with oral immunisation with nontypeable Haemophilus influenzae. Frontiers in Immunology 2011;2:7.
17. Collet JP, Shapiro S, Ernst P, Renzi P, Ducruet T, Robinson A, et al.Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 1997;156(6):1719-24.
18. Foxwell AR, Kyd J, Cripps A. Nontypeable Haemophilus influenzae: pathogenesis and prevention. Microbiology and Molecular Biology Reviews 1998;62(2):294-308.
19. Global Initiative for Chronic Obstructive Lung Disease. Pocket Guide to COPD Diagnosis, Management and Prevention. Revised. Bethesda: National Institutes of Health, 2011.
20. Herath A, Poole P. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD). Cochrane Database of Systematic Reviews 2013, Issue 11. [DOI: 10.1002/14651858.CD009764.pub2]
21. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
22. Lee TA, Sullivan ST, Buist AS. Estimating the future economic burden of COPD. ATS Proceedings 2006;3:A598.
23. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
24. Longo D, Fauci A, Kasper D, Hauser S, Jameson J, Loscalzo J. Harrison's Principles of Internal Medicine. 18. Vol. 1 & 2, New York, USA: McGraw-Hill, 2011.
25. Macfarlane J, Holmes W, Gard P. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax 2001;56(2):109-14. [DOI: 10.1136/thorax.56.2.109]
26. Murphy T, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. American Review of Respiratory Disease 1992;148:1067-83.
27. Otczyk DC, Cripps AW. Mucosal immunization: a realistic alternative. Human Vaccines 2010;6(12):1-29.
28. Otczyk D, Clancy R, Cripps A. Haemophilus influenzae and smoking-related obstructive airways disease. International Journal of Chronic Obstructive Pulmonary Disease 2011;6:345-51.
29. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
30. Van Alphen L, Jansen H, Dankert J. Virulence factors in the colonisation and persistence of bacteria in the airway. American Journal of Respiratory and Critical Care Medicine 1995;151:2094-100.
31. World Health Organization. Chronic obstructive pulmonary disease. http://www.who.int/respiratory/copd/en/ 2013 (accessed 25 April 2014).
32. Foxwell AR, Cripps AW, Dear KBG. Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitis. Cochrane Database of Systematic Reviews 2006, Issue 4. [DOI: 10.1002/14651858.CD001958.pub3]